Profile
Robert Siegle is currently the Director at Stratec Biomedical, the Co-Managing Director at STRATEC PS Holding GmbH, a Member-Management Board at STRATEC NewGen GmbH, and a Member-Supervisory Board at both STRATEC Biomedical Switzerland AG and STRATEC Services AG.
He previously worked as a Member-Management Board at Invitek Molecular GmbH and as the Head-Finance & Human Resources at STRATEC SE.
Dr. Siegle holds a doctorate degree from Eberhard Karls Universität Tübingen.
Robert Siegle active positions
| Companies | Position | Start |
|---|---|---|
Stratec Biomedical | Director/Board Member | 23/12/2012 |
STRATEC NewGen GmbH | Corporate Officer/Principal | 23/12/2012 |
Stratec Biomedical Switzerland AG | Director/Board Member | 01/03/2014 |
STRATEC PS Holding GmbH
STRATEC PS Holding GmbH Investment ManagersFinance Engages in management of assets | Chief Executive Officer | 01/05/2016 |
Former positions of Robert Siegle
| Companies | Position | End |
|---|---|---|
| STRATEC SE | Director of Finance/CFO | 31/08/2024 |
STRATEC Services AG | Director/Board Member | 18/06/2024 |
Invitek Molecular GmbH
Invitek Molecular GmbH BiotechnologyHealth Technology Researches and develops diagnostic products and proprietary core technologies for nucleic acid extraction and analysis | Corporate Officer/Principal | - |
Training of Robert Siegle
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
STRATEC SE
STRATEC SE Medical SpecialtiesHealth Technology Develops and manufactures fully automated analyzer systems in the fields of clinical diagnostics & biotechnology | Health Technology |
Eberhard Karls Universität Tübingen
Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Invitek Molecular GmbH
Invitek Molecular GmbH BiotechnologyHealth Technology Researches and develops diagnostic products and proprietary core technologies for nucleic acid extraction and analysis | Health Technology |
STRATEC NewGen GmbH | |
Stratec Biomedical | |
Stratec Biomedical Switzerland AG | |
STRATEC Services AG | |
STRATEC PS Holding GmbH
STRATEC PS Holding GmbH Investment ManagersFinance Engages in management of assets | Finance |
- Stock Market
- Insiders
- Robert Siegle
















